Genetics Health Law Policy Intellectual Property Pharmaceuticals Timo Minssen Will the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle? Read more: Will the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle?